Decomposing socioeconomic inequality in infant mortality in Iran AR Hosseinpoor, E Van Doorslaer, N Speybroeck, M Naghavi, ... International journal of epidemiology 35 (5), 1211-1219, 2006 | 317 | 2006 |
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study F Farzadfar, CJL Murray, E Gakidou, T Bossert, H Namdaritabar, ... The Lancet 379 (9810), 47-54, 2012 | 288 | 2012 |
Iran in transition G Danaei, F Farzadfar, R Kelishadi, A Rashidian, OM Rouhani, ... The Lancet 393 (10184), 1984-2005, 2019 | 217 | 2019 |
National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic N Peykari, H Hashemi, R Dinarvand, M Haji-Aghajani, R Malekzadeh, ... Journal of Diabetes & Metabolic Disorders 16, 1-7, 2017 | 204 | 2017 |
Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 202 | 2022 |
Socioeconomic inequality in infant mortality in Iran and across its provinces AR Hosseinpoor, K Mohammad, R Majdzadeh, M Naghavi, F Abolhassani, ... Bulletin of the World Health Organization 83, 837-844, 2005 | 182 | 2005 |
NASBOD 2013: design, definitions, and metrics (study protocol) F Farzadfar, A Delavari, R Malekzadeh, A Mesdaghinia, HR Jamshidi, ... ARCHIVES OF IRANIAN MEDICINE 17 (1), 7-15, 2014 | 115 | 2014 |
Health in Islamic republic of Iran A Marandi, F Azizi, B Larijani, HR Jamshidi Ministry of Health and Medical Education, Unicef 1, 120-1, 1998 | 95 | 1998 |
Measuring Iran's success in achieving Millennium Development Goal 4: a systematic analysis of under-5 mortality at national and subnational levels from 1990 to 2015 Y Mohammadi, M Parsaeian, P Mehdipour, A Khosravi, B Larijani, ... The Lancet Global Health 5 (5), e537-e544, 2017 | 75 | 2017 |
Determinants of seeking needed outpatient care in Iran: results from a national health services utilization survey AR Hosseinpoor, M Naghavi, SM Alavian, N Speybroeck, H Jamshidi, ... Archives of Iranian medicine 10 (4), 439-445, 2007 | 68 | 2007 |
National and subnational patterns of cause of death in Iran 1990–2015: applied methods A Sheidaei, K Gohari, A Kasaeian, N Rezaei, A Mansouri, A Khosravi, ... Archives of Iranian medicine 20 (1), 0-0, 2017 | 66 | 2017 |
Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study A Abdoli, R Aalizadeh, H Aminianfar, Z Kianmehr, A Teimoori, E Azimi, ... Reviews in medical virology 32 (3), e2305, 2022 | 64 | 2022 |
Burden of drug and alcohol use disorders in Iran: findings from the Global Burden of Disease Study 2010 B Moazen, M Shokoohi, A Noori, S Rahimzadeh, SS Moghaddam, ... Archives of Iranian medicine 18 (8), 0-0, 2015 | 56 | 2015 |
"We noticed that suddenly the country has become full of MRI". Policy makers' views on diffusion and use of health technologies in Iran M Palesh, C Tishelman, S Fredrikson, H Jamshidi, G Tomson, A Emami Health Research Policy and Systems 8, 1-10, 2010 | 54 | 2010 |
Diffusion of magnetic resonance imaging in Iran M Palesh, S Fredrikson, H Jamshidi, PM Jonsson, G Tomson International journal of technology assessment in health care 23 (2), 278-285, 2007 | 54 | 2007 |
Pre-marriage prevention of thalassaemia: report of a 100 000 case experience in Isfahan M Ghanei, P Adibi, M Movahedi, MA Khami, RL Ghasemi, T Azarm, ... Public health 111 (3), 153-156, 1997 | 53 | 1997 |
Some thoughts on medical education in the twenty-first century HR Jamshidi, DA Cook Medical Teacher 25 (3), 229-238, 2003 | 49 | 2003 |
Umbelliprenin shows antitumor, antiangiogenesis, antimetastatic, anti‐inflammatory, and immunostimulatory activities in 4T1 tumor‐bearing Balb/c mice M Rashidi, A Khalilnezhad, D Amani, H Jamshidi, A Muhammadnejad, ... journal of cellular physiology, 2018 | 43 | 2018 |
How is magnetic resonance imaging used in Iran? M Palesh, S Fredrikson, H Jamshidi, G Tomson, M Petzold International journal of technology assessment in health care 24 (4), 452-458, 2008 | 42 | 2008 |
Cost-effectiveness evaluation of quadrivalent human papilloma virus vaccine for HPV-related disease in Iran M Khatibi, HR Rasekh, Z Shahverdi Iranian journal of pharmaceutical research: IJPR 13 (Suppl), 225, 2014 | 41 | 2014 |